IMCL CP11-0805
Laufzeit: 01.01.2010 - 31.12.2011
Kurzfassung
A randomized, multicenter, open-label phase 3 study of Pemetrexed-Cisplatin chemotherapy plus IMC-11F8 versus Pemetrexed-Cisplatin chemotherapy alone in the first-line treatment of patients with nonsquamous stage IIIb or IV NSCLC
